Hung, T. W., Chang, H. R., Wu, S. W., Lin, C. K., & Lian, J. D. (2009). 賢移植術接受者的巨細胞病毒疾病:單一醫學中心之臨床經驗. Acta Nephrologica, 23(1), 21-25. https://www.airitilibrary.com/Article/Detail?DocID=10131671-200903-23-1-21-25-a
Chan, S. F. (2007). 合併Endostatin和PEDF抗血管新生因子應用於原位性肝細胞癌的基因療法 [master's thesis, National Taiwan University]. Airiti Library. https://doi.org/10.6342/NTU.2007.00225
Chang, C. S., Lin, S. F., Huang, S. M., Liu, T. C., Chen, T. P., & Yeh, C. J. (1997). 高劑量化學治療併血液幹細胞移植應用於復發或頑固性惡性淋巴瘤之臨床研究 -初報. The Kaohsiung Journal of Medical Sciences, 13(3), 149-154. https://doi.org/10.6452/KJMS.199703.0149